COMMUNIQUÉS West-GlobeNewswire

Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
24/06/2026
Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-Series Humanoid Robot; Pilot to Expand to Approximately 500 High School Students in Fall 2026; Onconetix Recently [...]
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
24/06/2026
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phase 2a portion in [...]
BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
24/06/2026
NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that its majority-owned subsidiary company DFSL Ltd. (“DFSL”) will showcase next-generation [...]
NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum
24/06/2026
NTHI Continues to Build Regulatory Momentum prior to Upcoming Phase 2 Data DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is entering one of the most [...]
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
24/06/2026
Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph , Wellington Management and founding investor LifeArc Ventures Proceeds support clinical development of [...]
FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing
24/06/2026
NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- FEATOL, a brand specializing in ergonomic support and protective products, has introduced its Anti Fatigue Mat , designed to help reduce the discomfort and fatigue commonly [...]
uniQure Announces Pricing of Upsized $225 Million Public Offering
24/06/2026
LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24/06/2026
ZUG, Switzerland , June 23, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today [...]
TWL Announces Expanded Online Access to GLP-1 Weight-Loss Care With Insurance and Self-Pay Options
24/06/2026
Telehealth program combines licensed medical care, insurance coordination, coaching and multiple prescription pathways for eligible patients New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- TWL today announced an [...]
Glass House Brands Provides Notice of Warrant Acceleration
24/06/2026
LONG BEACH, Calif. and TORONTO, June 23, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that it has elected to exercise its rights [...]
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
23/06/2026
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc [...]
AM Rx Announces Expanded Online Access and Insurance Support for Zepbound
23/06/2026
Telehealth company introduces an insurance-first weight-management pathway designed to help eligible patients navigate Zepbound coverage, prior authorization and ongoing virtual care New York, NY, June 23, 2026 (GLOBE [...]
Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
23/06/2026
CHICAGO, June 23, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has signed an [...]
MSK Masters Announces Release of Sonography of the Extremities - Techniques and Protocols, 5th Edition
23/06/2026
New edition expands interactive learning resources, updated imaging, and practical tools for musculoskeletal ultrasound professionals SUNMAN, IN, June 23, 2026 (GLOBE NEWSWIRE) -- MSK Masters has announced the release [...]
Acquisition of Own Shares
23/06/2026
Mechelen, Belgium; 23 June 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
23/06/2026
SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Nyxoah Organisera une Journée Investisseurs à New York le 8 juillet 2026
23/06/2026
Nyxoah Organisera une Journée Investisseurs à New York le 8 juillet 2026 L'équipe de direction et le Conseil d'administration aborderont l'exécution commerciale aux États-Unis, la stratégie de croissance et les [...]
Nyxoah to Host Investor Day in New York on July 8, 2026
23/06/2026
Nyxoah to Host Investor Day in New York on July 8, 2026 Leadership team and Board will discuss the U.S. commercial execution, growth strategy and key priorities Mont-Saint-Guibert, Belgium – June 23, 2026, 10:05 pm CET [...]
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
23/06/2026
-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary endpoint of endoscopic passability -- -- Study initiation on track, with [...]

Pages